Stephanie Alexia Cristina Silva Santos

Ms. Stephanie Alexia Cristina Silva Santos

Universidade Federal do Rio de Janeiro
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Journal of Cell Science
Verified
Journal Article
Closed access
PDF file
LSLuiz Eduardo B. Baggio Savio
Luiz Eduardo B. Baggio Savio
PMPaola de Andrade Mello
Paola de Andrade Mello
Stephanie Alexia Cristina Silva SantosStephanie Alexia Cristina Silva Santos
Stephanie Alexia Cristina Silva Santos
JSJúlia Costa de Sousa
Júlia Costa de Sousa
SOSuellen Darc Oliveira
Suellen Darc Oliveira
RCRobson Coutinho-Silva
Robson Coutinho-Silva
Macrophages are tissue-resident immune cells that are crucial for the initiation and maintenance of immune responses. Purinergic signaling modulates macrophage activity and impacts cellular plasticity. The ATP-activated purinergic receptor P2X7 (also known as P2RX7) has pro-inflammatory properties, which contribute to macrophage activation. P2X7 receptor signaling is, in turn, modulated by ectonucleotidases, such as CD39 (also known as ENTPD1), expressed in caveolae and lipid rafts. Here, we examined P2X7 receptor activity and determined impacts on ectonucleotidase localization and function in macrophages primed with lipopolysaccharide (LPS). First, we verified that ATP boosts CD39 activity and caveolin-1 protein expression in LPS-primed macrophages. Drugs that disrupt cholesterol-enriched domains – such as nystatin and methyl-β-cyclodextrin – decreased CD39 enzymatic activity in all circumstances. We noted that CD39 colocalized with lipid raft markers (flotillin-2 and caveolin-1) in macrophages that had been primed with LPS followed by treatment with ATP. P2X7 receptor inhibition blocked these ATP-mediated increases in caveolin-1 expression and inhibited the colocalization with CD39. Further, we found that STAT3 activation is significantly attenuated caveolin-1-deficient macrophages treated with LPS or LPS+BzATP. Taken together, our data suggest that P2X7 receptor triggers the initiation of lipid raft-dependent mechanisms that upregulates CD39 activity and could contribute to limit macrophage responses restoring homeostasis.

9 February 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
Stephanie Alexia Cristina Silva SantosStephanie Alexia Cristina Silva Santos
Stephanie Alexia Cristina Silva Santos
PPPedro Muanis Persechini
Pedro Muanis Persechini
BHBianca Monteiro Henriques-Santos
Bianca Monteiro Henriques-Santos
VBVictória Gabriela Bello-Santos
Victória Gabriela Bello-Santos
NCNewton G. Castro
Newton G. Castro
EKEleonora Kurtenbach
Eleonora Kurtenbach
The P2X7 receptor is a critical purinergic receptor in immune cells. Its activation was associated with cathepsin release into macrophage cytosol, suggesting its involvement in lysosomal membrane permeabilization (LMP) and leakage. Nevertheless, the mechanisms by which P2X7 receptor activation induces LMP and leakage are unclear. This study investigated cellular mechanisms associated with endosomal and lysosomal leakage triggered by P2X7 receptor activation. We found that ATP at 500 μM and 5 mM (but not 50 μM) induced LMP in non-stimulated peritoneal macrophages. This effect was not observed in P2X7-deficient or A740003-pretreated macrophages. We found that the P2X7 receptor and pannexin-1 channels mediate calcium influx that might be important for activating specific ion channels (TRPM2 and two-pore channels) on the membranes of late endosomes and lysosomes leading to LMP leakage and consequent cathepsin release. These findings suggest the critical role of the P2X7 receptor in inflammatory and infectious diseasesvialysosomal dysfunction.

Verified
Journal Article
Open access
PDF file
VAVirginia Sara Grancieri do Amaral
Virginia Sara Grancieri do Amaral
Stephanie Alexia Cristina Silva SantosStephanie Alexia Cristina Silva Santos
Stephanie Alexia Cristina Silva Santos
PAPaula Cavalcante de Andrade
Paula Cavalcante de Andrade
JNJenifer Nowatzki
Jenifer Nowatzki
NJNilton Silva Júnior
Nilton Silva Júnior
EKEleonora Kurtenbach
Eleonora Kurtenbach
Psd1 is a pea plant defensin which can be actively expressed in Pichia pastoris and shows broad antifungal activity. This activity is dependent on fungal membrane glucosylceramide (GlcCer), which is also important for its internalization, nuclear localization, and endoreduplication. Certain cancer cells present a lipid metabolism imbalance resulting in the overexpression of GlcCer in their membrane. In this work, in vitroassays using B16F10 cells showed that labeled fluorescein isothiocyanate FITC-Psd1 internalized into live cultured cells and targeted the nucleus, which underwent fragmentation, exhibiting approximately 60% of cells in the sub-G0/G1 stage. This phenomenon was dependent on GlcCer, and the participation of cyclin-F was suggested. In a murine lung metastatic melanoma model, intravenous injection of Psd1 together with B16F10 cells drastically reduced the number of nodules at concentrations above 0.5 mg/kg. Additionally, the administration of 1 mg/kg Psd1 decreased the number of lung inflammatory cells to near zero without weight loss, unlike animals that received melanoma cells only. It is worth noting that 1 mg/kg Psd1 alone did not provoke inflammation in lung tissue or weight or vital signal losses over 21 days, inferring no whole animal cytotoxicity. These results suggest that Psd1 could be a promising prototype for human lung anti-metastatic melanoma therapy.